News | Radiology Business | October 25, 2018

Principal investigator of two landmark mammography trials will identify clinical and socioeconomic research opportunities for ACR

Etta Pisano Named American College of Radiology Chief Research Officer

October 25, 2018 — Breast imaging research pioneer Etta Pisano, M.D., FACR, has been named chief research officer (CRO) of the American College of Radiology. Pisano is the first woman to hold this ACR position. She previously served as chief science officer (CSO) solely for of the ACR Center for Research and Innovation (CRI).

“Dr. Pisano is a giant in the clinical research community. She will identify clinical and socioeconomic research opportunities that can advance the practice of radiology and improve patient care. We are proud to have her as chief research officer for the entire College which will allow us to tap her talents and experience across the ACR,” said William T. Thorwarth, M.D., FACR, chief executive officer of the American College of Radiology.  

Pisano may be best known for leading landmark clinical research trials. She is principal investigator for the Tomosynthesis Mammographic Imaging Screening Trial (TMIST). Involving nearly 165,000 women, TMIST compares standard digital mammography (2-D) to digital breast tomosynthesis (DBT) to determine if DBT is more effective at reducing advanced breast cancers. TMIST will create the world’s largest aggregation of data, images and biospecimens arising from a clinical research trial.

Pisano previously led the Digital Mammography Screening Trial (DMIST) — which accrued 49,528 women to compare effectiveness of digital mammography to film mammography. DMIST results, published in the New England Journal of Medicine in 2005,1 dramatically changed breast cancer screening guidelines and reimbursement.

For more information: www.acr.org

Reference

1. Pisano E.D., Gatsonis C., Hendrick E., et al. Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening. New England Journal of Medicine, Oct. 27, 2005. DOI: 10.1056/NEJMoa052911


Related Content

News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Artificial Intelligence

Nov. 25, 2025 – Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI ...

Time November 25, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
Subscribe Now